Ember Therapeutics Stock Shares Outstanding
EMBT Stock | USD 0.0001 0.00 0.00% |
Ember Therapeutics fundamentals help investors to digest information that contributes to Ember Therapeutics' financial success or failures. It also enables traders to predict the movement of Ember Pink Sheet. The fundamental analysis module provides a way to measure Ember Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ember Therapeutics pink sheet.
Ember |
Ember Therapeutics Company Shares Outstanding Analysis
Ember Therapeutics' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Ember Therapeutics Shares Outstanding | 40 M |
Most of Ember Therapeutics' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ember Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition |
Based on the latest financial disclosure, Ember Therapeutics has 40 M of shares currently outstending. This is 77.84% lower than that of the sector and 62.57% lower than that of the Shares Outstanding industry. The shares outstanding for all United States stocks is 93.0% higher than that of the company.
Ember Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ember Therapeutics' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Ember Therapeutics could also be used in its relative valuation, which is a method of valuing Ember Therapeutics by comparing valuation metrics of similar companies.Ember Therapeutics is currently under evaluation in shares outstanding category among related companies.
Ember Fundamentals
Current Valuation | 12 M | |||
Shares Outstanding | 40 M | |||
Shares Owned By Insiders | 65.00 % | |||
Price To Earning | 26.61 X | |||
EBITDA | 9.4 M | |||
Net Income | (23.24 K) | |||
Cash And Equivalents | 71.22 M | |||
Cash Per Share | 0.41 X | |||
Total Debt | 75 K | |||
Debt To Equity | 0.33 % | |||
Current Ratio | 3.32 X | |||
Book Value Per Share | (0.74) X | |||
Cash Flow From Operations | (16.72 K) | |||
Beta | 3.33 | |||
Market Capitalization | 926.88 K | |||
Total Asset | 184 | |||
Retained Earnings | 289 K | |||
Working Capital | 58.61 M | |||
Current Asset | 83.91 M | |||
Current Liabilities | 25.3 M | |||
Net Asset | 184 |
About Ember Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ember Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ember Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ember Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Ember Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ember Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ember Therapeutics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Ember Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ember Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ember Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ember Therapeutics to buy it.
The correlation of Ember Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ember Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ember Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ember Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ember Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Ember Therapeutics information on this page should be used as a complementary analysis to other Ember Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Ember Pink Sheet analysis
When running Ember Therapeutics' price analysis, check to measure Ember Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ember Therapeutics is operating at the current time. Most of Ember Therapeutics' value examination focuses on studying past and present price action to predict the probability of Ember Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ember Therapeutics' price. Additionally, you may evaluate how the addition of Ember Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |